Skip to main content
Erschienen in:

21.03.2020 | Case Report

Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation

verfasst von: Jun Toda, Tetsuo Maeda, Keigo Akuta, Shinsuke Kusakabe, Tomoaki Ueda, Jiro Fujita, Hirohiko Shibayama, Kenji Oritani, Yukitoshi Takahashi, Yuzuru Kanakura

Erschienen in: International Journal of Hematology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Various central nervous system (CNS) complications may occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which can result in severe clinical problems. Diagnosis is often difficult, as distinctive clinical symptoms may be absent and different neurological disorders may exhibit similar symptoms. Despite the fact that antibodies responding to brain cell surface antigens have become well recognized in several CNS disorders, cases of autoimmune CNS disorders after allo-HSCT have rarely been reported. Here, we report on a patient who developed encephalitis associated with antibodies against N-methyl-d-aspartate (NMDA)-type glutamate receptor (GluR) after allo-HSCT. To the best of our knowledge, this is the first report of the involvement of antibodies against NMDA-type GluR in post-transplantation encephalitis. Autoimmunity to NMDA-type GluR may have contributed to neurological complications after transplantation in unresolved cases.
Literatur
1.
Zurück zum Zitat Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:388–97.CrossRef Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:388–97.CrossRef
2.
Zurück zum Zitat Lin TA, Gau JP, Liu YC, Ko PS, Wang HY, Chien SH, et al. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. Int J Hematol. 2019;109:584–92.CrossRef Lin TA, Gau JP, Liu YC, Ko PS, Wang HY, Chien SH, et al. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. Int J Hematol. 2019;109:584–92.CrossRef
3.
Zurück zum Zitat Rggiu M, Cuccuini W, Mokhtari K, Meignin V, Peffault de Latour R, Robin M, et al. Case report: central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature. Medicine (Baltimore). 2017;96(42):e8303.CrossRef Rggiu M, Cuccuini W, Mokhtari K, Meignin V, Peffault de Latour R, Robin M, et al. Case report: central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature. Medicine (Baltimore). 2017;96(42):e8303.CrossRef
4.
Zurück zum Zitat Min GJ, Park S, Park SS, Yoon JH, Lee SE, Cho BS, et al. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation. Int J Hematol. 2019;110:635–9.CrossRef Min GJ, Park S, Park SS, Yoon JH, Lee SE, Cho BS, et al. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation. Int J Hematol. 2019;110:635–9.CrossRef
5.
Zurück zum Zitat Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.CrossRef Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.CrossRef
6.
Zurück zum Zitat Takahashi Y, Nishida T, Kimizu T, Oboshi T, Horino A, Koike T, et al. Autoimmune-mediated encephalitis with antibodies to NMDA-type GluRs: early clinical diagnosis. In: Yamanouchi H, Moshé S, Okumura A, Cross H, Galanopoulou AS, Dale R, et al., editors. Acute encephalopathy and encephalitis in infancy and its related disorders. St. Louis: Elsevier; 2017. p. 151–156. Takahashi Y, Nishida T, Kimizu T, Oboshi T, Horino A, Koike T, et al. Autoimmune-mediated encephalitis with antibodies to NMDA-type GluRs: early clinical diagnosis. In: Yamanouchi H, Moshé S, Okumura A, Cross H, Galanopoulou AS, Dale R, et al., editors. Acute encephalopathy and encephalitis in infancy and its related disorders. St. Louis: Elsevier; 2017. p. 151–156.
7.
Zurück zum Zitat Takahashi Y, Mori H, Mishina M, Watanabe M, Kondo N, Shimomura J, et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia. 2005;46(Suppl 5):152–8.CrossRef Takahashi Y, Mori H, Mishina M, Watanabe M, Kondo N, Shimomura J, et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia. 2005;46(Suppl 5):152–8.CrossRef
8.
Zurück zum Zitat Fukuyama T, Takahashi Y, Kubota Y, Mogami Y, Imai K, Kondo Y, et al. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res. 2015;113:34–433.CrossRef Fukuyama T, Takahashi Y, Kubota Y, Mogami Y, Imai K, Kondo Y, et al. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res. 2015;113:34–433.CrossRef
9.
Zurück zum Zitat Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, et al. Antibodies to N-methyl-d-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012;251:90–3.CrossRef Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, et al. Antibodies to N-methyl-d-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012;251:90–3.CrossRef
10.
Zurück zum Zitat Ikura T, Katsuse O, Chiba Y, Takahashi Y, Fujishiro H, Kamada A, et al. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies. Neurosci Lett. 2016;628:201–6.CrossRef Ikura T, Katsuse O, Chiba Y, Takahashi Y, Fujishiro H, Kamada A, et al. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies. Neurosci Lett. 2016;628:201–6.CrossRef
11.
Zurück zum Zitat Hayata Y, Hamada K, Sakurai Y, Sugimoto I, Mannen T, Takahashi Y. Anti-glutamate ε2 receptor antibody-positive and anti-N-methyl-d-aspartate receptor antibody-negative lobar encephalitis presenting as global aphasia and swallowing apraxia. Case Rep Neurol. 2014;6:291–6.CrossRef Hayata Y, Hamada K, Sakurai Y, Sugimoto I, Mannen T, Takahashi Y. Anti-glutamate ε2 receptor antibody-positive and anti-N-methyl-d-aspartate receptor antibody-negative lobar encephalitis presenting as global aphasia and swallowing apraxia. Case Rep Neurol. 2014;6:291–6.CrossRef
12.
Zurück zum Zitat Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRef Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRef
13.
Zurück zum Zitat Takahashi Y, Kimizu Y, Koike T, Horino A. Autoimmune mediated encephalitis/encephalopathy (in Japanese). Neurolog Ther. 2016;33:19–26. Takahashi Y, Kimizu Y, Koike T, Horino A. Autoimmune mediated encephalitis/encephalopathy (in Japanese). Neurolog Ther. 2016;33:19–26.
14.
Zurück zum Zitat Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology. 2009;72:1960–1.CrossRef Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology. 2009;72:1960–1.CrossRef
15.
Zurück zum Zitat Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77.CrossRef Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77.CrossRef
16.
Zurück zum Zitat Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866–75.CrossRef Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866–75.CrossRef
17.
Zurück zum Zitat Derksen SJ, Goraj B, Molenaar JG, van der Hoeven JG. Severe anti NMDA encephalitis and EBV infection. Neth J Crit Care. 2013;17:19–211. Derksen SJ, Goraj B, Molenaar JG, van der Hoeven JG. Severe anti NMDA encephalitis and EBV infection. Neth J Crit Care. 2013;17:19–211.
18.
Zurück zum Zitat Zhao CZ, Erickson J, Dalmau J. Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology. 2012;79:e41–44.CrossRef Zhao CZ, Erickson J, Dalmau J. Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology. 2012;79:e41–44.CrossRef
19.
Zurück zum Zitat Randall A, Saif H, Anu J, Larner AJ. Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression. Pract Neurol. 2018;18:320–2.CrossRef Randall A, Saif H, Anu J, Larner AJ. Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression. Pract Neurol. 2018;18:320–2.CrossRef
20.
Zurück zum Zitat Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, et al. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5:e497.CrossRef Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, et al. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5:e497.CrossRef
21.
Zurück zum Zitat Garré J, Sprengers M, Van Melkebeke D, Laureys G. EBV-NMDA double positive encephalitis in an immunocompromised patient. J Neurol Sci. 2019;396:76–7.CrossRef Garré J, Sprengers M, Van Melkebeke D, Laureys G. EBV-NMDA double positive encephalitis in an immunocompromised patient. J Neurol Sci. 2019;396:76–7.CrossRef
22.
Zurück zum Zitat Konen FF, Schwenkenbecher P, Jendretzky KF, Hümmert MW, Wegner F, Stangel M, et al. Severe anti-N-methyl-d-aspartate receptor encephalitis under immunosuppression after liver transplantation. Front Neurol. 2019;10:987.CrossRef Konen FF, Schwenkenbecher P, Jendretzky KF, Hümmert MW, Wegner F, Stangel M, et al. Severe anti-N-methyl-d-aspartate receptor encephalitis under immunosuppression after liver transplantation. Front Neurol. 2019;10:987.CrossRef
23.
Zurück zum Zitat Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199:155–9.CrossRef Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199:155–9.CrossRef
24.
Zurück zum Zitat Niehusmann P, Mittelstaedt T, Bien CG, Drexler JF, Grote A, Schoch S, et al. Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia. 2010;51:2478–83.CrossRef Niehusmann P, Mittelstaedt T, Bien CG, Drexler JF, Grote A, Schoch S, et al. Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia. 2010;51:2478–83.CrossRef
25.
Zurück zum Zitat Niehusmann P, Widman G, Eis-Hübinger AM, Greschus S, Robens BK, Grote A, et al. Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology. 2016;36:376–80.CrossRef Niehusmann P, Widman G, Eis-Hübinger AM, Greschus S, Robens BK, Grote A, et al. Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology. 2016;36:376–80.CrossRef
26.
Zurück zum Zitat Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e245.CrossRef Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e245.CrossRef
27.
Zurück zum Zitat Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Sci World J. 2013;2013:867389.CrossRef Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Sci World J. 2013;2013:867389.CrossRef
Metadaten
Titel
Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation
verfasst von
Jun Toda
Tetsuo Maeda
Keigo Akuta
Shinsuke Kusakabe
Tomoaki Ueda
Jiro Fujita
Hirohiko Shibayama
Kenji Oritani
Yukitoshi Takahashi
Yuzuru Kanakura
Publikationsdatum
21.03.2020
Verlag
Springer Singapore
Erschienen in
International Journal of Hematology / Ausgabe 2/2020
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02859-0

Neu im Fachgebiet Onkologie

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.